Nvidia in talks with insurers to share AI chip lending risks

By Splitfeed EditorialLast updated Sep 29, 2026, 17:01 UTC

On September 29, 2026, the Financial Times reported that Nvidia is in active discussions with insurers to take on financial risks tied to loans backed by its AI chips. The talks are part of a broader push by Nvidia to extend chip financing to buyers beyond large technology companies, a move that introduces greater default risk. Separately, CEO Jensen Huang told reporters that Nvidia stock is undervalued, citing profit growth that has outpaced the company's price-to-earnings ratio relative to historical averages, and described the US-China AI race as "important and consequential." No specific insurers, terms, or dollar figures have been disclosed.

The significance of the move lies in what it reveals about the current state of AI infrastructure financing. Wall Street appetite for further AI investment has shown signs of hesitation, and Nvidia's turn to insurance structures suggests that the pool of creditworthy chip buyers is being stretched. Transferring lending risk into the broader financial system through insurance instruments raises questions about how that risk is ultimately priced and who holds it if defaults rise. The comparison some critics draw to mortgage-backed securities before 2007, or the telecom build-out of the late 1990s, frames the dispute: is this responsible risk management or the seeding of a systemic problem?

The Pro-AI camp reads Huang's public comments as a confidence signal. Accounts including AI Tech News and Les Echos pointed to the low price-to-earnings ratio as evidence management sees the stock as genuinely undervalued, while Huang himself dismissed fears about AI escaping human control as anthropomorphism. The Anti-AI camp is sharply critical of the insurance strategy itself. Jonathan Atkinson wrote that Nvidia has "committed to spreading systemic risk throughout the entire financial system," and Chrononaut questioned why society should reorganize around AI while Wall Street grows hesitant to fund it. The Middle Ground camp raises more specific structural doubts. The account 670rv questioned whether any insurer would accept chips with a four-to-six year lifespan as viable collateral, calling the proposition "a stretch," while Jornal de Negócios argued that the pace of safety limit discovery needs to accelerate before deployment expands further.

The clearest near-term signals to watch are whether any insurer publicly confirms participation, what collateral standards emerge for depreciating chips, and whether Nvidia's next earnings report shows the financing expansion translating into sustained revenue growth or rising credit exposure.